Adapt and overcome in response to the Covid-19 crisis
April 23, 2020
MedinCell launches Regulatory Development of mdc-WWM Program
April 22, 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis
April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
April 6, 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell
January 28, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
January 13, 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
December 3, 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association
September 10, 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
September 4, 2019
